-
1
-
-
33845884027
-
Integrative molecular concept modeling of prostate cancer progression
-
Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ, Shah RB, Chinnaiyan AM,. Integrative molecular concept modeling of prostate cancer progression. Nat Genet 2007; 39: 41-51.
-
(2007)
Nat Genet
, vol.39
, pp. 41-51
-
-
Tomlins, S.A.1
Mehra, R.2
Rhodes, D.R.3
Cao, X.4
Wang, L.5
Dhanasekaran, S.M.6
Kalyana-Sundaram, S.7
Wei, J.T.8
Rubin, M.A.9
Pienta, K.J.10
Shah, R.B.11
Chinnaiyan, A.M.12
-
2
-
-
56449126966
-
Profiling human androgen receptor mutations reveals treatment effects in a mouse model of prostate cancer
-
O'Mahony OA, Steinkamp MP, Albertelli MA, Brogley M, Rehman H, Robins DM,. Profiling human androgen receptor mutations reveals treatment effects in a mouse model of prostate cancer. Mol Cancer Res 2008; 6: 1691-701.
-
(2008)
Mol Cancer Res
, vol.6
, pp. 1691-1701
-
-
O'Mahony, O.A.1
Steinkamp, M.P.2
Albertelli, M.A.3
Brogley, M.4
Rehman, H.5
Robins, D.M.6
-
3
-
-
42949165515
-
A role for the androgen-receptor in clinically localized and advanced prostate cancer
-
Mohler JL,. A role for the androgen-receptor in clinically localized and advanced prostate cancer. Best Pract Res Clin Endocr Metab 2008; 22: 357-72.
-
(2008)
Best Pract Res Clin Endocr Metab
, vol.22
, pp. 357-372
-
-
Mohler, J.L.1
-
4
-
-
45349108158
-
Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential
-
Ricciardelli C, Jackson MW, Choong CS, Stahl J, Marshall VR, Horsfall DJ, Tilley WD,. Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential. Prostate 2008; 68: 830-8.
-
(2008)
Prostate
, vol.68
, pp. 830-838
-
-
Ricciardelli, C.1
Jackson, M.W.2
Choong, C.S.3
Stahl, J.4
Marshall, V.R.5
Horsfall, D.J.6
Tilley, W.D.7
-
5
-
-
3943069729
-
PC-3 cells with enhanced androgen receptor signaling: A model for clonal selection in prostate cancer
-
Buchanan G, Craft PS, Yang M, Cheong A, Prescott J, Jia L, Coetzee GA, Tilley WD,. PC-3 cells with enhanced androgen receptor signaling: a model for clonal selection in prostate cancer. Prostate 2004; 60: 352-66.
-
(2004)
Prostate
, vol.60
, pp. 352-366
-
-
Buchanan, G.1
Craft, P.S.2
Yang, M.3
Cheong, A.4
Prescott, J.5
Jia, L.6
Coetzee, G.A.7
Tilley, W.D.8
-
6
-
-
4944246790
-
Targeting the androgen receptor: Improving outcomes for castration-resistant prostate cancer
-
Scher HI, Buchanan G, Gerald W, Butler LM, Tilley WD,. Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer. Endocr Relat Cancer 2004; 11: 459-76.
-
(2004)
Endocr Relat Cancer
, vol.11
, pp. 459-476
-
-
Scher, H.I.1
Buchanan, G.2
Gerald, W.3
Butler, L.M.4
Tilley, W.D.5
-
7
-
-
33846603663
-
Androgen receptor coregulators and their involvement in the development and progression of prostate cancer
-
Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM,. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer 2007; 120: 719-33.
-
(2007)
Int J Cancer
, vol.120
, pp. 719-733
-
-
Chmelar, R.1
Buchanan, G.2
Need, E.F.3
Tilley, W.4
Greenberg, N.M.5
-
8
-
-
12844274300
-
Mutation of the androgen receptor causes oncogenic transformation of the prostate
-
Han G, Buchanan G, Ittmann M, Harris JM, Yu X, Demayo FJ, Tilley W, Greenberg NM,. Mutation of the androgen receptor causes oncogenic transformation of the prostate. Proc Natl Acad Sci USA 2005; 102: 1151-6.
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 1151-1156
-
-
Han, G.1
Buchanan, G.2
Ittmann, M.3
Harris, J.M.4
Yu, X.5
Demayo, F.J.6
Tilley, W.7
Greenberg, N.M.8
-
9
-
-
14944364652
-
Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease
-
Ricciardelli C, Choong CS, Buchanan G, Vivekanandan S, Neufing P, Stahl J, Marshall VR, Horsfall DJ, Tilley WD,. Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease. Prostate 2005; 63: 19-28.
-
(2005)
Prostate
, vol.63
, pp. 19-28
-
-
Ricciardelli, C.1
Choong, C.S.2
Buchanan, G.3
Vivekanandan, S.4
Neufing, P.5
Stahl, J.6
Marshall, V.R.7
Horsfall, D.J.8
Tilley, W.D.9
-
10
-
-
0032743557
-
Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a
-
Zhao XY, Boyle B, Krishnan AV, Navone NM, Peehl DM, Feldman D,. Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a. J Urol 1999; 162: 2192-9.
-
(1999)
J Urol
, vol.162
, pp. 2192-2199
-
-
Zhao, X.Y.1
Boyle, B.2
Krishnan, A.V.3
Navone, N.M.4
Peehl, D.M.5
Feldman, D.6
-
11
-
-
0033152164
-
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist
-
Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, Rajeshkumar B, Balk SP,. Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist. Cancer Res 1999; 59: 2511-5.
-
(1999)
Cancer Res
, vol.59
, pp. 2511-2515
-
-
Taplin, M.E.1
Bubley, G.J.2
Ko, Y.J.3
Small, E.J.4
Upton, M.5
Rajeshkumar, B.6
Balk, S.P.7
-
12
-
-
0036847896
-
Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer
-
Hyytinen ER, Haapala K, Thompson J, Lappalainen I, Roiha M, Rantala I, Helin HJ, Janne OA, Vihinen M, Palvimo JJ, Koivisto PA,. Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer. Lab Invest 2002; 82: 1591-8.
-
(2002)
Lab Invest
, vol.82
, pp. 1591-1598
-
-
Hyytinen, E.R.1
Haapala, K.2
Thompson, J.3
Lappalainen, I.4
Roiha, M.5
Rantala, I.6
Helin, H.J.7
Janne, O.A.8
Vihinen, M.9
Palvimo, J.J.10
Koivisto, P.A.11
-
13
-
-
0035815749
-
Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer
-
Han G, Foster BA, Mistry S, Buchanan G, Harris JM, Tilley WD, Greenberg NM,. Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer. J Biol Chem 2001; 276: 11204-13.
-
(2001)
J Biol Chem
, vol.276
, pp. 11204-11213
-
-
Han, G.1
Foster, B.A.2
Mistry, S.3
Buchanan, G.4
Harris, J.M.5
Tilley, W.D.6
Greenberg, N.M.7
-
14
-
-
0026562430
-
The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens
-
Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GG, Jenster G, Trapman J, Brinkmann AO, Mulder E,. The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol 1992; 41: 665-9.
-
(1992)
J Steroid Biochem Mol Biol
, vol.41
, pp. 665-669
-
-
Veldscholte, J.1
Berrevoets, C.A.2
Ris-Stalpers, C.3
Kuiper, G.G.4
Jenster, G.5
Trapman, J.6
Brinkmann, A.O.7
Mulder, E.8
-
15
-
-
0033601249
-
Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain
-
He B, Kemppainen JA, Voegel JJ, Gronemeyer H, Wilson EM,. Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. J Biol Chem 1999; 274: 37219-25.
-
(1999)
J Biol Chem
, vol.274
, pp. 37219-37225
-
-
He, B.1
Kemppainen, J.A.2
Voegel, J.J.3
Gronemeyer, H.4
Wilson, E.M.5
-
16
-
-
0030669765
-
Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
-
Ikonen T, Palvimo JJ, Janne OA,. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem 1997; 272: 29821-8.
-
(1997)
J Biol Chem
, vol.272
, pp. 29821-29828
-
-
Ikonen, T.1
Palvimo, J.J.2
Janne, O.A.3
-
17
-
-
0036219918
-
Androgen receptor (AR) coregulators: An overview
-
Heinlein CA, Chang C,. Androgen receptor (AR) coregulators: an overview. Endocr Rev 2002; 23: 175-200.
-
(2002)
Endocr Rev
, vol.23
, pp. 175-200
-
-
Heinlein, C.A.1
Chang, C.2
-
18
-
-
0032190991
-
Evolution of the androgen receptor: Structure-function implications
-
Thornton JW, Kelley DB,. Evolution of the androgen receptor: structure-function implications. Bioessays 1998; 20: 860-9.
-
(1998)
Bioessays
, vol.20
, pp. 860-869
-
-
Thornton, J.W.1
Kelley, D.B.2
-
19
-
-
3142672066
-
An Androgen Receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP)
-
He B, Bai S, Hnat AT, Kalman RI, Minges JT, Patterson C, Wilson EM,. An Androgen Receptor NH2-terminal conserved motif interacts with the COOH terminus of the Hsp70-interacting protein (CHIP). J Biol Chem 2004; 279: 30643-53.
-
(2004)
J Biol Chem
, vol.279
, pp. 30643-30653
-
-
He, B.1
Bai, S.2
Hnat, A.T.3
Kalman, R.I.4
Minges, J.T.5
Patterson, C.6
Wilson, E.M.7
-
20
-
-
77951645885
-
Androgen regulation of gene expression
-
Lamont KR, Tindall DJ,. Androgen regulation of gene expression. Adv Cancer Res 2010; 107: 137-62.
-
(2010)
Adv Cancer Res
, vol.107
, pp. 137-162
-
-
Lamont, K.R.1
Tindall, D.J.2
-
21
-
-
1842612441
-
Molecular determinants of resistance to antiandrogen therapy
-
Chen CD, Welsbie DS, Tran C, Baek SH, Chen R, Vessella R, Rosenfeld MG, Sawyers CL,. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004; 10: 33-9.
-
(2004)
Nat Med
, vol.10
, pp. 33-39
-
-
Chen, C.D.1
Welsbie, D.S.2
Tran, C.3
Baek, S.H.4
Chen, R.5
Vessella, R.6
Rosenfeld, M.G.7
Sawyers, C.L.8
-
22
-
-
0037129827
-
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
-
Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F,. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.
-
(2002)
Genome Biol
, vol.3
-
-
Vandesompele, J.1
De Preter, K.2
Pattyn, F.3
Poppe, B.4
Van Roy, N.5
De Paepe, A.6
Speleman, F.7
-
23
-
-
77958026106
-
Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development
-
Bianco-Miotto T, Chiam K, Buchanan G, Jindal S, Day TK, Thomas M, Pickering MA, O'Loughlin MA, Ryan NK, Raymond WA, Horvath LG, Kench JG, et al. Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development. Cancer Epidemiol Biomarkers Prev 2010; 19: 2611-22.
-
(2010)
Cancer Epidemiol Biomarkers Prev
, vol.19
, pp. 2611-2622
-
-
Bianco-Miotto, T.1
Chiam, K.2
Buchanan, G.3
Jindal, S.4
Day, T.K.5
Thomas, M.6
Pickering, M.A.7
O'Loughlin, M.A.8
Ryan, N.K.9
Raymond, W.A.10
Horvath, L.G.11
Kench, J.G.12
-
24
-
-
0034665124
-
Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
-
Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM,. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 2000; 60: 5165-70.
-
(2000)
Cancer Res
, vol.60
, pp. 5165-5170
-
-
Butler, L.M.1
Agus, D.B.2
Scher, H.I.3
Higgins, B.4
Rose, A.5
Cordon-Cardo, C.6
Thaler, H.T.7
Rifkind, R.A.8
Marks, P.A.9
Richon, V.M.10
-
25
-
-
77954255681
-
Integrative genomic profiling of human prostate cancer
-
Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, Antipin Y, Mitsiades N, et al. Integrative genomic profiling of human prostate cancer. Cancer Cell 2010; 18: 11-22.
-
(2010)
Cancer Cell
, vol.18
, pp. 11-22
-
-
Taylor, B.S.1
Schultz, N.2
Hieronymus, H.3
Gopalan, A.4
Xiao, Y.5
Carver, B.S.6
Arora, V.K.7
Kaushik, P.8
Cerami, E.9
Reva, B.10
Antipin, Y.11
Mitsiades, N.12
-
26
-
-
1542574202
-
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
-
Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, Reuter V, Gerald WL,. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol 2004; 164: 217-27.
-
(2004)
Am J Pathol
, vol.164
, pp. 217-227
-
-
Holzbeierlein, J.1
Lal, P.2
Latulippe, E.3
Smith, A.4
Satagopan, J.5
Zhang, L.6
Ryan, C.7
Smith, S.8
Scher, H.9
Scardino, P.10
Reuter, V.11
Gerald, W.L.12
-
27
-
-
34249709906
-
Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
-
Chandran U, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, Michalopoulos G, Becich M, Monzon F,. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer 2007; 7: 64.
-
(2007)
BMC Cancer
, vol.7
, pp. 64
-
-
Chandran, U.1
Ma, C.2
Dhir, R.3
Bisceglia, M.4
Lyons-Weiler, M.5
Liang, W.6
Michalopoulos, G.7
Becich, M.8
Monzon, F.9
-
28
-
-
2142717404
-
Gene expression profiling predicts clinical outcome of prostate cancer
-
Glinsky GV, Glinskii AB, Stephenson AJ, Hoffman RM, Gerald WL,. Gene expression profiling predicts clinical outcome of prostate cancer. J Clin Invest 2004; 113: 913-23.
-
(2004)
J Clin Invest
, vol.113
, pp. 913-923
-
-
Glinsky, G.V.1
Glinskii, A.B.2
Stephenson, A.J.3
Hoffman, R.M.4
Gerald, W.L.5
-
29
-
-
3142756502
-
Open source clustering software
-
de Hoon MJL, Imoto S, Nolan J, Miyano S,. Open source clustering software. Bioinformatics 2004; 20: 1453-4.
-
(2004)
Bioinformatics
, vol.20
, pp. 1453-1454
-
-
De Hoon, M.J.L.1
Imoto, S.2
Nolan, J.3
Miyano, S.4
-
30
-
-
38348998587
-
Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates /'neuroendocrine phenotype' in LNCaP prostate tumor cells
-
Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K, Figarella-Branger D, Martin PM, Ouafik LH,. Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates /'neuroendocrine phenotype' in LNCaP prostate tumor cells. Oncogene 2007; 27: 506-18.
-
(2007)
Oncogene
, vol.27
, pp. 506-518
-
-
Berenguer, C.1
Boudouresque, F.2
Dussert, C.3
Daniel, L.4
Muracciole, X.5
Grino, M.6
Rossi, D.7
Mabrouk, K.8
Figarella-Branger, D.9
Martin, P.M.10
Ouafik, L.H.11
-
31
-
-
33646728919
-
GREB1 is a novel androgen-regulated gene required for prostate cancer growth
-
Rae JM, Johnson MD, Cordero KE, Scheys JO, Larios JM, Gottardis MM, Pienta KJ, Lippman ME,. GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Prostate 2006; 66: 886-94.
-
(2006)
Prostate
, vol.66
, pp. 886-894
-
-
Rae, J.M.1
Johnson, M.D.2
Cordero, K.E.3
Scheys, J.O.4
Larios, J.M.5
Gottardis, M.M.6
Pienta, K.J.7
Lippman, M.E.8
-
32
-
-
44349168861
-
Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate
-
Bettendorf O, Schmidt H, Staebler A, Grobholz R, Heinecke A, Boecker W, Hertle L, Semjonow A,. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate. Genes Chromosomes Cancer 2008; 47: 565-72.
-
(2008)
Genes Chromosomes Cancer
, vol.47
, pp. 565-572
-
-
Bettendorf, O.1
Schmidt, H.2
Staebler, A.3
Grobholz, R.4
Heinecke, A.5
Boecker, W.6
Hertle, L.7
Semjonow, A.8
-
33
-
-
34247855834
-
CCR2 expression correlates with prostate cancer progression
-
Lu Y, Cai Z, Xiao G, Liu Y, Keller ET, Yao Z, Zhang J,. CCR2 expression correlates with prostate cancer progression. J Cell Biochem 2007; 101: 676-85.
-
(2007)
J Cell Biochem
, vol.101
, pp. 676-685
-
-
Lu, Y.1
Cai, Z.2
Xiao, G.3
Liu, Y.4
Keller, E.T.5
Yao, Z.6
Zhang, J.7
-
34
-
-
37249080636
-
NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model
-
Diallo JS, Aldejmah A, Mouhim AF, Peant B, Fahmy MA, Koumakpayi IH, Sircar K, Begin LR, Mes-Masson AM, Saad F,. NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model. Clin Cancer Res 2007; 13: 7044-52.
-
(2007)
Clin Cancer Res
, vol.13
, pp. 7044-7052
-
-
Diallo, J.S.1
Aldejmah, A.2
Mouhim, A.F.3
Peant, B.4
Fahmy, M.A.5
Koumakpayi, I.H.6
Sircar, K.7
Begin, L.R.8
Mes-Masson, A.M.9
Saad, F.10
-
35
-
-
0036615803
-
Structure and expression of Strabismus 1 gene on human chromosome 1q21-q23
-
Katoh M,. Structure and expression of Strabismus 1 gene on human chromosome 1q21-q23. Int J Oncol 2002; 20: 1197-203.
-
(2002)
Int J Oncol
, vol.20
, pp. 1197-1203
-
-
Katoh, M.1
-
36
-
-
0035051248
-
Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma
-
Macoska JA, Xu J, Ziemnicka D, Schwab TS, Rubin MA, Kotula L,. Loss of expression of human spectrin src homology domain binding protein 1 is associated with 10p loss in human prostatic adenocarcinoma. Neoplasia 2001; 3: 99-104.
-
(2001)
Neoplasia
, vol.3
, pp. 99-104
-
-
Macoska, J.A.1
Xu, J.2
Ziemnicka, D.3
Schwab, T.S.4
Rubin, M.A.5
Kotula, L.6
-
37
-
-
77955373045
-
Kallikreins on steroids: Structure, function, and hormonal regulation of prostate-specific antigen and the extended Kallikrein locus
-
Lawrence MG, Lai J, Clements JA,. Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended Kallikrein locus. Endocr Rev 2010: er.2009-0034.
-
(2010)
Endocr Rev
-
-
Lawrence, M.G.1
Lai, J.2
Clements, J.A.3
-
38
-
-
0036117240
-
Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo
-
Ouafik LH, Sauze S, Boudouresque F, Chinot O, Delfino C, Fina F, Vuaroqueaux V, Dussert C, Palmari J, Dufour H, Grisoli F, Casellas P, et al. Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo. Am J Pathol 2002; 160: 1279-92.
-
(2002)
Am J Pathol
, vol.160
, pp. 1279-1292
-
-
Ouafik, L.H.1
Sauze, S.2
Boudouresque, F.3
Chinot, O.4
Delfino, C.5
Fina, F.6
Vuaroqueaux, V.7
Dussert, C.8
Palmari, J.9
Dufour, H.10
Grisoli, F.11
Casellas, P.12
-
39
-
-
0035477480
-
Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein
-
Yahata T, Shao W, Endoh H, Hur J, Coser KR, Sun H, Ueda Y, Kato S, Isselbacher KJ, Brown M, Shioda T,. Selective coactivation of estrogen-dependent transcription by CITED1 CBP/p300-binding protein. Genes Dev 2001; 15: 2598-612.
-
(2001)
Genes Dev
, vol.15
, pp. 2598-2612
-
-
Yahata, T.1
Shao, W.2
Endoh, H.3
Hur, J.4
Coser, K.R.5
Sun, H.6
Ueda, Y.7
Kato, S.8
Isselbacher, K.J.9
Brown, M.10
Shioda, T.11
-
40
-
-
67449135819
-
Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors
-
Kela I, Harmelin A, Waks T, Orr-Urtreger A, Domany E, Eshhar Z,. Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors. Prostate 2009; 69: 1034-44.
-
(2009)
Prostate
, vol.69
, pp. 1034-1044
-
-
Kela, I.1
Harmelin, A.2
Waks, T.3
Orr-Urtreger, A.4
Domany, E.5
Eshhar, Z.6
-
41
-
-
77950907621
-
Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: Comparison to human prostate cancer
-
Calvo A, Perez-Stable C, Segura V, Catena R, Guruceaga E, Nguewa P, Blanco D, Parada L, Reiner T, Green JE,. Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: comparison to human prostate cancer. Prostate 2010; 70: 630-45.
-
(2010)
Prostate
, vol.70
, pp. 630-645
-
-
Calvo, A.1
Perez-Stable, C.2
Segura, V.3
Catena, R.4
Guruceaga, E.5
Nguewa, P.6
Blanco, D.7
Parada, L.8
Reiner, T.9
Green, J.E.10
-
42
-
-
50449088732
-
Androgen receptor is a tumor suppressor and proliferator in prostate cancer
-
Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S, Chang C,. Androgen receptor is a tumor suppressor and proliferator in prostate cancer. Proc Natl Acad Sci USA 2008; 105: 12182-7.
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, pp. 12182-12187
-
-
Niu, Y.1
Altuwaijri, S.2
Lai, K.P.3
Wu, C.T.4
Ricke, W.A.5
Messing, E.M.6
Yao, J.7
Yeh, S.8
Chang, C.9
-
43
-
-
12844287338
-
Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype
-
Evangelou AI, Winter SF, Huss WJ, Bok RA, Greenberg NM,. Steroid hormones, polypeptide growth factors, hormone refractory prostate cancer, and the neuroendocrine phenotype. J Cell Biochem 2004; 91: 671-83.
-
(2004)
J Cell Biochem
, vol.91
, pp. 671-683
-
-
Evangelou, A.I.1
Winter, S.F.2
Huss, W.J.3
Bok, R.A.4
Greenberg, N.M.5
-
44
-
-
67649710472
-
Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer
-
Carey JP, Asirvatham AJ, Galm O, Ghogomu TA, Chaudhary J,. Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer. BMC Cancer 2009; 9: 173.
-
(2009)
BMC Cancer
, vol.9
, pp. 173
-
-
Carey, J.P.1
Asirvatham, A.J.2
Galm, O.3
Ghogomu, T.A.4
Chaudhary, J.5
-
45
-
-
22244458283
-
Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products
-
Kim J, Yang P, Suraokar M, Sabichi AL, Llansa ND, Mendoza G, Subbarayan V, Logothetis CJ, Newman RA, Lippman SM, Menter DG,. Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products. Cancer Res 2005; 65: 6189-98.
-
(2005)
Cancer Res
, vol.65
, pp. 6189-6198
-
-
Kim, J.1
Yang, P.2
Suraokar, M.3
Sabichi, A.L.4
Llansa, N.D.5
Mendoza, G.6
Subbarayan, V.7
Logothetis, C.J.8
Newman, R.A.9
Lippman, S.M.10
Menter, D.G.11
-
46
-
-
33745218275
-
Id proteins expression in prostate cancer: High-level expression of Id-4 in primary prostate cancer is associated with development of metastases
-
Yuen H-F, Chua C-W, Chan Y-P, Wong Y-C, Wang X, Chan K-W,. Id proteins expression in prostate cancer: high-level expression of Id-4 in primary prostate cancer is associated with development of metastases. Mod Pathol 2006; 19: 931-41.
-
(2006)
Mod Pathol
, vol.19
, pp. 931-941
-
-
Yuen, H.-F.1
Chua, C.-W.2
Chan, Y.-P.3
Wong, Y.-C.4
Wang, X.5
Chan, K.-W.6
-
47
-
-
79951512852
-
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
-
Ding Z, Wu CJ, Chu GC, Xiao Y, Ho D, Zhang J, Perry SR, Labrot ES, Wu X, Lis R, Hoshida Y, Hiller D, et al. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 2011; 470: 269-73.
-
(2011)
Nature
, vol.470
, pp. 269-273
-
-
Ding, Z.1
Wu, C.J.2
Chu, G.C.3
Xiao, Y.4
Ho, D.5
Zhang, J.6
Perry, S.R.7
Labrot, E.S.8
Wu, X.9
Lis, R.10
Hoshida, Y.11
Hiller, D.12
-
48
-
-
0036698536
-
Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization
-
Kasahara K, Taguchi T, Yamasaki I, Kamada M, Yuri K, Shuin T,. Detection of genetic alterations in advanced prostate cancer by comparative genomic hybridization. Cancer Genet Cytogenet 2002; 137: 59-63.
-
(2002)
Cancer Genet Cytogenet
, vol.137
, pp. 59-63
-
-
Kasahara, K.1
Taguchi, T.2
Yamasaki, I.3
Kamada, M.4
Yuri, K.5
Shuin, T.6
-
49
-
-
0344943234
-
Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families
-
Xu J, Gillanders EM, Isaacs SD, Chang B-l, Wiley KE, Zheng SL, Jones M, Gildea D, Riedesel E, Albertus J, Freas-Lutz D, Markey C, et al. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families. Prostate 2003; 57: 320-5.
-
(2003)
Prostate
, vol.57
, pp. 320-325
-
-
Xu, J.1
Gillanders, E.M.2
Isaacs, S.D.3
Chang, B.-L.4
Wiley, K.E.5
Zheng, S.L.6
Jones, M.7
Gildea, D.8
Riedesel, E.9
Albertus, J.10
Freas-Lutz, D.11
Markey, C.12
-
50
-
-
31944447676
-
Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer
-
Pang S-T, Weng W-H, Flores-Morales A, Johansson B, Pourian MR, Nilsson P, Pousette Å, Larsson C, Norstedt G,. Cytogenetic and expression profiles associated with transformation to androgen-resistant prostate cancer. Prostate 2006; 66: 157-72.
-
(2006)
Prostate
, vol.66
, pp. 157-172
-
-
Pang, S.-T.1
Weng, W.-H.2
Flores-Morales, A.3
Johansson, B.4
Pourian, M.R.5
Nilsson, P.6
Pousette, Å.7
Larsson, C.8
Norstedt, G.9
|